Efficacy of recombinant human soluble thrombomodulin for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a single arm, non-randomized prospective clinical trial.
Sho HayakawaYasuo MatsuzawaTamako IrieHagino RikitakeNoriaki OkadaYasuo SuzukiPublished in: Multidisciplinary respiratory medicine (2016)
The study was registered with University Hospital Medical Information Network Clinical Trial Registry (UMIN-CTR) in October 2012 (UMIN000009082).
Keyphrases
- clinical trial
- idiopathic pulmonary fibrosis
- recombinant human
- double blind
- phase ii
- open label
- phase iii
- placebo controlled
- respiratory failure
- chronic obstructive pulmonary disease
- study protocol
- healthcare
- liver failure
- interstitial lung disease
- drug induced
- rheumatoid arthritis
- extracorporeal membrane oxygenation
- intensive care unit
- network analysis
- replacement therapy
- mechanical ventilation
- acute respiratory distress syndrome
- smoking cessation